奥曲肽与泮托拉唑联用方案治疗急性胰腺炎的临床疗效观察  

Clinical curative effect of octreotide and pantoprazole combined regimen in treatment of acute pancreatitis

作　　者：刘彩丽 

机构地区：[1]凌源市中心医院呼吸消化内科,辽宁朝阳122500

出　　处：《中国伤残医学》2015年第4期10-11,共2页Chinese Journal of Trauma and Disability Medicine

摘　　要：目的：探究奥曲肽与泮托拉唑联用方案治疗急性胰腺炎的临床效果。方法：选择我院2013年5月-2014年5月收治的90例急性胰腺炎患者作为研究对象,根据用药分为观察组（联用方案治疗）和对照组（常规治疗）各45例,比较2组治疗效果的差异性。结果：观察组痊愈率为66.67%,有效率为28.89%,总有效率为95.56%,治疗效果显著优于对照组,P〈0.05,具有统计学差异。结论：奥曲肽与泮托拉唑联用方案能够显著提高急性胰腺炎治疗效果,是较为理想的用药方案。Objective：To explore the clinical effect of octreotide and pantoprazole combined regimen in the treatment of acute pancreatitis. Methods：from 2013 May to 2014 May,90 cases with acute pancreatitis in our hospital were as the research object, according to drug use were divided into observation group （ combination therapy） and control group （ routine treatment） of 45 cases;Compared two groups of treatment effect. Results：in the observation group, the cure rate is 66. 67%, effective rate was 28. 89%, the total effective rate was 95. 56%, the treatment effect was better than the control group, P 〈0. 05, with significant difference. Conclusion：octreotide and pantoprazole combined scheme could improve the effect of the treatment of acute pancreatitis, might be an ideal medication.

关 键 词：奥曲肽 泮托拉唑 急性胰腺炎/药物疗法 合理用药 

分 类 号：R657.5[医药卫生—外科学]